No Data
Sunshine Biopharma Delays Financial Report Filing
Sunshine Biopharma Signs Agreement for Rights to Market Two Generic Antibiotics
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Sunshine Biopharma Announces Canadian Subsidiary Nora Pharma Acquired Two Gastrointestinal Drugs; Launches Prucalopride For Chronic Constipation, Second Drug Launch Planned in 9 Months. Gastrointestinal Market Worth In Excess Of C$200M Per Year.
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
